Ornithylaspartate clinical trials

Studies by the year they started

13 studies that test it; most in 2023 (3)

Who runs them

Industry 0 · Other 13

Medical University of Graz (1) · Centro Regional para el Estudio de las Enfermedades Digestivas (1) · Mahidol University (1) · Hospital General de Mexico (1) · Dayanand Medical College and Hospital (1) · Imperial College London (1) · Air Force Military Medical University, China (1) · Aga Khan University (1)

Often tested with

Tested in the same studies.

Lactulose (2) · Rifaximin (1) · Polyethylene Glycols (1) · Acetylcysteine (1) · Pioglitazone (1) · Poly(ADP-ribose) Polymerase Inhibitors (1)

Studies

Open first, then newest update. How each study uses ornithylaspartate is read from its arms, and is right about nine times in ten.

Testing it · 13

• An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard TherapyRecruitingPhase 2Fudan UniversityNCT07117630Written as L-Ornithine L-Aspartate
• Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic EncephalopathyNot yet recruitingPhase 4Jinnah Postgraduate Medical CentreNCT05920213Written as L-ornithine L-aspartate
• Effect of L-ornithine-L-aspertate (LOLA) on the Gut MicrobiomeCompletedPhase 4Medical University of GrazNCT05737030Written as L-ornithine L-aspartate
• Efficacy of L-ornithine L-aspartate and Therapeutic Plasma Exchange Versus Plasma Exchange Alone in Lowering Ammonia and Improving Outcomes in Pediatric Acute Liver Failure.Status unknownNot applicableInstitute of Liver and Biliary Sciences, IndiaNCT05778461Written as L-ornithine L-Aspartate
• Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.CompletedPhase 4Centro Regional para el Estudio de las Enfermedades DigestivasNCT01041755Written as L-ornithine-L-aspartate
• Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic EncephalopathyCompletedPhase 4Mahidol UniversityNCT00740142Written as L-ornithine-L-aspartate and lactulose
• Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal BleedingCompletedPhase 4Hospital General de MexicoNCT02158182Written as L-ornithine L-aspartate
• L-ornithine L-aspartate in Overt Hepatic EncephalopathyCompletedPhase 4Dayanand Medical College and HospitalNCT01722578Written as L-ornithine L-aspartate
• Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.CompletedNot applicableImperial College LondonNCT00305591Written as l-ornithine l-aspartate
• The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPSCompletedPhase 2/3Air Force Military Medical University, ChinaNCT01440829Written as L-ornithine-L-aspartate
• Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal EncephalopathyStatus unknownPhase 4Hospital de Clinicas de Porto AlegreNCT00896831Written as L-ornithine-L-aspartate
• Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver FailureStatus unknownPhase 2All India Institute of Medical Sciences, New DelhiNCT00470314Written as L-Ornithine L-Aspartate
• Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic EncephalopathyCompletedPhase 3Aga Khan UniversityNCT00433368Written as L-Ornithine L-Aspartate

Codes

What other systems call ornithylaspartate · ClinicalTrials.gg INT002262

• MeSH (NLM) C002939ornithylaspartateOne source NLM
• RxNorm 32541One source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.